BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 5:12:00 PM | Browse: 838 | Download: 957
 |
Received |
|
2013-11-20 14:16 |
 |
Peer-Review Started |
|
2013-11-20 16:19 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
|
 |
Revised |
|
2014-02-11 09:28 |
 |
Second Decision |
|
2014-04-09 09:23 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-04-09 11:01 |
 |
Articles in Press |
|
2014-05-23 11:01 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-04-14 21:39 |
 |
Typeset the Manuscript |
|
2014-07-03 17:03 |
 |
Publish the Manuscript Online |
|
2014-07-21 17:17 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Treatment of Crohn’s disease in pregnant women: Drug and multidisciplinary approaches
|
Manuscript Source |
Invited Manuscript |
All Author List |
Didia Bismara Cury and Alan C Moss |
Funding Agency and Grant Number |
|
Corresponding Author |
Didia Bismara Cury, Director, Center of Inflammatory Bowel Disease, Clinica Scope, Campo Grande, MS 79002212, Brazil. didia_cury@uol.com.br |
Key Words |
Pregnancy; Drugs; Inflammatory bowel disease; Crohn’s disease; Breastfeeding |
Core Tip |
Patients should be encouraged to postpone conception until their Crohn’s disease (CD) is in remission. Monitoring of nutritional status remains important in patients with small bowel CD; folic acid, vitamin D and vitamin B12 may all need to be supplemented. Most drug treatments are safe in pregnancy, based on observational data, including 5-aminosalicylic acid, thiopurines, anti-tumor necrosis factor, and anti-integrins. Methotrexate should be avoided due to its teratogenicity. Cesarean section is only indicated from a CD perspective in women with active perianal disease at the time of delivery; all others can have a normal vaginal delivery. |
Publish Date |
2014-07-21 17:17 |
Citation |
Cury DB, Moss AC. Treatment of Crohn’s disease in pregnant women: Drug and multidisciplinary approaches. World J Gastroenterol 2014; 20(27): 8790-8795 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i27/8790.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i27.8790 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345